OSUR News and Press, OraSure Technologies Inc. From 08/29/22

The federal government's program of providing free at-home COVID-19 tests sent by mail will end on Sept. 2 due to a lack of funding, NBC News reported. The covid.gov website states that the program will end on that date as "Congress hasn't provided additional funding to re...

Gainers: Euro Tech Holdings ( CLWT ) +63% . Invitae ( NVTA ) +59% . Allego ( ALLG ) +54% . Grove Collaborative ( GROV ) +52% . BioAtla ( BCAB ) +40% . The Trade Desk ( TTD ) +37% . Chicken Soup for the Soul Entert...

The shares of diagnostics company OraSure Technologies ( NASDAQ: OSUR ) climbed ~25% in the morning hours Wednesday, the highest since March 2020, as Wall Street reacted to a sharp quarterly beat and above consensus guidance issued by the management with its Q2 2022 financ...

Gainers: OraSure Technologies ( OSUR ) +28% . BioAtla ( BCAB ) +24% . Catalyst Pharmaceuticals ( CPRX ) +16% . Clovis Oncology ( CLVS ) +13% . Quanterix ( QTRX ) +13% . Losers: Singular Genomics Systems ( OMIC ...

OraSure Technologies, Inc. (OSUR) Q2 2022 Earnings Conference Call August 9, 2022 17:00 ET Company Participants Scott Gleason - Senior Vice President of Investor Relations & Corporate Communications Carrie Manner - President & Chief Executive Officer Kath...

OraSure Technologies press release ( NASDAQ: OSUR ): Q2 Non-GAAP EPS of $0.00 beats by $0.11 . Revenue of $80.2M (+39.2% Y/Y) beats by $10.29M . For 3Q22, revenue of $90M to $95M (vs. consensus of $75.59M). OraSure has appointed Kenneth J. McGrath ...

InteliSwab ® revenue of $43.1 million in Q2, up 95% sequentially with significant scaling in production InteliSwab ® gross margins improve sequentially by over 2,000 basis points GAAP gross margin of 34.4%, a decrease of 200 basis points s...

BETHLEHEM, Pa., Aug. 02, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2022 second quarter financial results and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Tuesday, August 9, 2022. A...

BETHLEHEM, Pa., July 28, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today its ongoing commitment to fight the hepatitis C epidemic. July 28 is commemorated aro...

BETHLEHEM, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies, announced today that its OMNIgene ® •GUT DNA and RNA product ( OMR-205 ) is now a...